High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

Detalles Bibliográficos
Autores principales: McNamara, Lucy A., Topaz, Nadav, Wang, Xin, Hariri, Susan, Fox, LeAnne, MacNeil, Jessica R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687588/
https://www.ncbi.nlm.nih.gov/pubmed/28704351
http://dx.doi.org/10.15585/mmwr.mm6627e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687588/
https://www.ncbi.nlm.nih.gov/pubmed/28704351
http://dx.doi.org/10.15585/mmwr.mm6627e1

Ejemplares similares